-
Discovery of flavonoids from Pterogyne nitens with potent activity against Zika virus protease and helicase
Vol. 1, 2019 -111212 -
Carbamoylimidazoles as Potent Cruzain Inhibitors with in Vitro and in Vivo Trypanocidal Activity: a Structure–Based Drug Design Approach
Vol. 1, 2019 -108992 -
Antiviral candidates discovery based on the structure of the yellow fever NS5 RNA-dependent RNA polymerase enzyme.
Vol. 1, 2019 -112680 -
Structural biology and ligand search for the NS5 protein of the Zika virus
Vol. 1, 2019 -114179 -
Structural Studies of the NS2B-NS3 Protease Complex of the Brazilian Circulating Strain of Yellow Fever Virus
Vol. 1, 2019 -114165
Publications in other proceedings
-
SBBf 2023
DISCOVERY OF RNA-DEPENDENT RNA POLYMERASE COMPLEX (RDRP) INHIBITORS FROM SARS-COV-2 AS HITS FOR COVID-19 DRUG DEVELOPMENT
-
BrazMedChem 2022
Synthesis and evaluation of possible ligands of the Zika virus NS3 helicase based on fragment screening
-
BrazMedChem 2022
Investigation of compounds with functional inhibition action of SARS CoV-2 non-structural protein Nsp13 (helicase)
-
BrazMedChem 2022
Integration of virtual screening and experimental method to identify new Mpro of SARS-CoV-2 inhibitors.
-
43ª RASBQ
Discovery of novel Zika virus NS3 protein inhibitors through the integration of docking, machine learning models and experimental evaluation
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
